Haoming Xia

537 total citations
21 papers, 390 citations indexed

About

Haoming Xia is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haoming Xia has authored 21 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haoming Xia's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and RNA modifications and cancer (7 papers). Haoming Xia is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and RNA modifications and cancer (7 papers). Haoming Xia collaborates with scholars based in China, Hong Kong and United States. Haoming Xia's co-authors include Yunfu Cui, Jianting Long, Judy Wai Ping Yam, Ziyue Huang, Ming Jiang, Caiwen Ou, Xiang Ao, Yifan Zhu, Dayue Liu and Yi Xu and has published in prestigious journals such as Biomaterials, Cancer Letters and Clinica Chimica Acta.

In The Last Decade

Haoming Xia

21 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haoming Xia China 13 253 215 51 48 43 21 390
Yu‐Kai Tseng Taiwan 10 241 1.0× 153 0.7× 74 1.5× 47 1.0× 25 0.6× 19 413
Haolong Qi China 9 215 0.8× 188 0.9× 35 0.7× 24 0.5× 31 0.7× 16 321
Zhenyu Nie China 11 241 1.0× 148 0.7× 43 0.8× 120 2.5× 44 1.0× 23 391
Jianli Hu China 11 207 0.8× 168 0.8× 97 1.9× 36 0.8× 45 1.0× 16 398
Wu-Ping Zheng China 11 225 0.9× 124 0.6× 49 1.0× 57 1.2× 22 0.5× 27 349
Cristina Ciocan Romania 10 277 1.1× 194 0.9× 40 0.8× 37 0.8× 18 0.4× 24 419
Hongfang Sun China 13 395 1.6× 128 0.6× 93 1.8× 49 1.0× 40 0.9× 32 535
Guoquan Tao China 12 313 1.2× 239 1.1× 39 0.8× 38 0.8× 22 0.5× 22 423
Yongwei Hu China 13 188 0.7× 137 0.6× 107 2.1× 66 1.4× 25 0.6× 32 435
Hongxing Huang China 14 316 1.2× 117 0.5× 79 1.5× 36 0.8× 28 0.7× 43 468

Countries citing papers authored by Haoming Xia

Since Specialization
Citations

This map shows the geographic impact of Haoming Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoming Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoming Xia more than expected).

Fields of papers citing papers by Haoming Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoming Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoming Xia. The network helps show where Haoming Xia may publish in the future.

Co-authorship network of co-authors of Haoming Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Haoming Xia. A scholar is included among the top collaborators of Haoming Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoming Xia. Haoming Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Pengfei, et al.. (2024). Dendritic quinary PtRhMoCoFe high-entropy alloy as a robust immunosensing nanoplatform for ultrasensitive detection of biomarker. Bioelectrochemistry. 157. 108639–108639. 17 indexed citations
2.
Wang, Jiangang, Xinlei Zou, Jianjun Gao, et al.. (2023). Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies. Frontiers in Medicine. 10. 1120621–1120621. 18 indexed citations
3.
Xia, Haoming, Ziyue Huang, Xudong Zhao, et al.. (2023). Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma. Frontiers in Oncology. 13. 1204715–1204715. 2 indexed citations
4.
Huang, Ziyue, Haoming Xia, Yunfu Cui, Judy Wai Ping Yam, & Yi Xu. (2022). Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 25 indexed citations
5.
Qiu, Ni, et al.. (2022). IFT20 Confers Paclitaxel Resistance by Triggering β-arrestin-1 to Modulate ASK1 Signaling in Breast Cancer. Molecular Cancer Research. 21(3). 214–227. 1 indexed citations
6.
Xia, Haoming, Ziyue Huang, Yi Xu, Judy Wai Ping Yam, & Yunfu Cui. (2022). Reprogramming of central carbon metabolism in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 153. 113485–113485. 21 indexed citations
7.
Huang, Ziyue, Zhensheng Wang, Haoming Xia, et al.. (2022). Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy. Clinica Chimica Acta. 539. 162–169. 4 indexed citations
8.
Xia, Haoming, Ziyue Huang, Zhensheng Wang, et al.. (2022). Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma. Frontiers in Oncology. 12. 953668–953668. 12 indexed citations
9.
Xia, Haoming, Ziyue Huang, Shuqiang Liu, et al.. (2021). Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma. Frontiers in Oncology. 11. 653846–653846. 3 indexed citations
10.
Huang, Ziyue, Haoming Xia, Shuqiang Liu, et al.. (2021). The Mechanism and Clinical Significance of Circular RNAs in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 714665–714665. 10 indexed citations
11.
Wang, Zhongrui, Liang Yu, Haoming Xia, et al.. (2021). Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value. Biomedicine & Pharmacotherapy. 138. 111529–111529. 20 indexed citations
12.
Huang, Jia, Xiang Ao, Wei‐Bang Guo, et al.. (2021). TMB and TCR Are Correlated Indicators Predictive of the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer. Frontiers in Oncology. 11. 740427–740427. 7 indexed citations
13.
Xia, Haoming, Ziyue Huang, Shuqiang Liu, et al.. (2021). LncRNA DiGeorge syndrome critical region gene 5: A crucial regulator in malignant tumors. Biomedicine & Pharmacotherapy. 141. 111889–111889. 5 indexed citations
14.
15.
16.
Xia, Haoming, et al.. (2019). Long noncoding RNA FEZF1-AS1 in human cancers. Clinica Chimica Acta. 497. 20–26. 22 indexed citations
17.
Ao, Xiang, et al.. (2018). lincRNA‑p21 inhibits the progression of non‑small cell lung cancer via targeting miR‑17‑5p. Oncology Reports. 41(2). 789–800. 22 indexed citations
18.
Xia, Haoming, Jianting Long, Ruifen Zhang, Xiaosong Yang, & Zhefu Ma. (2015). MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression. Biomedicine & Pharmacotherapy. 75. 105–110. 16 indexed citations
19.
Long, Jianting, Caiwen Ou, Haoming Xia, Yifan Zhu, & Dayue Liu. (2015). MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression. Tumor Biology. 36(11). 8697–8702. 53 indexed citations
20.
Wei, Jinhuan, Tuck−Yun Cheang, Bing Tang, et al.. (2012). The inhibition of human bladder cancer growth by calcium carbonate/CaIP6 nanocomposite particles delivering AIB1 siRNA. Biomaterials. 34(4). 1246–1254. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu‐Kai Tseng Breakdown of academic impact, for papers by Haolong Qi Breakdown of academic impact, for papers by Zhenyu Nie Breakdown of academic impact, for papers by Jianli Hu Breakdown of academic impact, for papers by Wu-Ping Zheng Breakdown of academic impact, for papers by Cristina Ciocan Breakdown of academic impact, for papers by Hongfang Sun Breakdown of academic impact, for papers by Guoquan Tao Breakdown of academic impact, for papers by Yongwei Hu Breakdown of academic impact, for papers by Hongxing Huang
Rankless by CCL
2026